دورية أكاديمية

Conventional Spinal Chordomas: Investigation of SMARCB1/INI1 Protein Expression, Genetic Alterations in SMARCB1 Gene, and Clinicopathological Features in 89 Patients

التفاصيل البيبلوغرافية
العنوان: Conventional Spinal Chordomas: Investigation of SMARCB1/INI1 Protein Expression, Genetic Alterations in SMARCB1 Gene, and Clinicopathological Features in 89 Patients
المؤلفون: Margherita Maioli, Stefania Cocchi, Marco Gambarotti, Stefania Benini, Giovanna Magagnoli, Gabriella Gamberi, Cristiana Griffoni, Alessandro Gasbarrini, Riccardo Ghermandi, Luigi Emanuele Noli, Chiara Alcherigi, Cristina Ferrari, Giuseppe Bianchi, Sofia Asioli, Elettra Pignotti, Alberto Righi
المصدر: Cancers, Vol 16, Iss 16, p 2808 (2024)
بيانات النشر: MDPI AG, 2024.
سنة النشر: 2024
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: conventional chordoma, SMARCB1/INI1, SMARCB1 gene, FISH analysis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: The partial loss of SMARCB1/INI1 expression has recently been reported in skull base conventional chordomas, with possible therapeutic implications. We retrospectively analyzed 89 patients with conventional spinal chordomas to investigate the differences in the immunohistochemical expression of SMARCB1/INI1 and the underlying genetic alterations in the SMARCB1 gene. Moreover, we assessed the correlation of clinicopathological features (age, gender, tumor size, tumor location, surgical margins, Ki67 labelling index, SMARCB1/INI1 pattern, previous surgery, previous treatment, type of surgery, and the Charlson Comorbidity Index) with patient survival. Our cohort included 51 males and 38 females, with a median age at diagnosis of 61 years. The median tumor size at presentation was 5.9 cm. The 5-year overall survival (OS) and 5-year disease-free survival (DFS) rates were 90.8% and 54.9%, respectively. Partial SMARCB1/INI1 loss was identified in 37 (41.6%) patients with conventional spinal chordomas (27 mosaic and 10 clonal). The most frequent genetic alteration detected was the monoallelic deletion of a portion of the long arm of chromosome 22, which includes the SMARCB1 gene. Partial loss of SMARCB1/INI1 was correlated with cervical–thoracic–lumbar tumor location (p = 0.033) and inadequate surgical margins (p = 0.007), possibly due to the high degree of tumor invasiveness in this site. Among all the considered clinicopathological features related to patient survival, only tumor location in the sacrococcygeal region and adequate surgical margins positively impacted DFS. In conclusion, partial SMARCB1/INI1 loss, mostly due to 22q deletion, was detected in a significant number of patients with conventional spinal chordomas and was correlated with mobile spine location and inadequate surgical margins.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2072-6694
Relation: https://www.mdpi.com/2072-6694/16/16/2808; https://doaj.org/toc/2072-6694
DOI: 10.3390/cancers16162808
URL الوصول: https://doaj.org/article/b9846ce98fcd404595cae4edcb84b018
رقم الأكسشن: edsdoj.b9846ce98fcd404595cae4edcb84b018
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20726694
DOI:10.3390/cancers16162808